Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System

Status unconfirmed

Conditions studied: Coronary In-stent Restenosis

In brief

The study will evaluate the long-term safety and efficacy of intravascular beta radiation therapy to treat coronary in-stent restenosis using the Beta-Cath(TM) 3.5F System; data will be collected retrospectively on patients treated with the Beta-Cath™ 3.5F System in routine clinical practice following FDA pre-market approval of the System. Outcomes will be reported up to 5 years following treatment.

Key facts

Study ID
NCT00852176
Run by
Best Vascular, Inc.
People needed
200
Starts
2009-05-01
Expected to finish
2020-12-01
Last updated by the study team
2018-07-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.